title: Comparative effects of cytosine arabinoside and a prostaglandin E2 antagonist, AH6809, on chondrogenesis in serum-free cultures of chick limb mesenchyme.
abstract: The present study was designed to compare effects of an established inhibitor of cell proliferation and growth, cytosine arabinoside (Ara C), with that of a prostaglandin E2 (PGE2) antagonist, AH6809, on chondrogenesis in cultured mesenchyme derived from stage 25 chick limb buds. Continuous treatment of cell cultures with 10(-4) M AH6809 prevented completely the twofold increases in DNA content of control cultures which occurred between Day 1 and Day 5 of culture and also produced 90% inhibition of chondrogenesis occurring in control cultures during this same period. Treatment of cells with Ara C (0.1-0.5 microgram/ml) produced equivalent inhibition of DNA content during the same time period; however, chondrogenesis, as evaluated on Day 5 of cell culture, remained at approximately 90% of control cultures. These results indicate that the inhibitory effect of PGE2 receptor blockade on cell growth in these cultures cannot account for the potent inhibitory effects observed on differentiation of cartilage and provide further evidence in support of the notion that PGE2 plays an important initiating role in the process of chondrocyte differentiation within limb mesenchyme.
authors.affiliation: Department of Neurobiology and Anatomy, Bowman Gray School of Medicine of Wake Forest University, Winston-Salem, North Carolina 27103.
authors.forename: D M
authors.initials: DM
authors.lastname: Biddulph
authors.forename: A A
authors.initials: AA
authors.lastname: Capehart
authors.forename: T C
authors.initials: TC
authors.lastname: Beasley
mesh_terms: D000818:Animals; D002356:Cartilage / Q000166:cytology* / Q000378:metabolism / Q000648:ultrastructure; D002454:Cell Differentiation / Q000187:drug effects; D002455:Cell Division / Q000187:drug effects; D002478:Cells, Cultured; D002642:Chick Embryo; D003561:Cytarabine / Q000494:pharmacology*; D004247:DNA / Q000378:metabolism; D015232:Dinoprostone / Q000502:physiology; D005314:Embryonic and Fetal Development / Q000187:drug effects; D005121:Extremities / Q000196:embryology*; D008648:Mesoderm / Q000166:cytology* / Q000378:metabolism / Q000648:ultrastructure; D011448:Prostaglandin Antagonists / Q000494:pharmacology*; D011982:Receptors, Prostaglandin / Q000187:drug effects / Q000502:physiology; D014966:Xanthenes / Q000494:pharmacology*; D044004:Xanthones
chemical_list: D011448:Prostaglandin Antagonists; D011982:Receptors, Prostaglandin; D014966:Xanthenes; D044004:Xanthones; D003561:Cytarabine; C053876:6-isopropoxy-9-oxoxanthene-2-carboxylic acid; D004247:DNA; D015232:Dinoprostone